GB9202915D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9202915D0
GB9202915D0 GB929202915A GB9202915A GB9202915D0 GB 9202915 D0 GB9202915 D0 GB 9202915D0 GB 929202915 A GB929202915 A GB 929202915A GB 9202915 A GB9202915 A GB 9202915A GB 9202915 D0 GB9202915 D0 GB 9202915D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929202915A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB929202915A priority Critical patent/GB9202915D0/en
Publication of GB9202915D0 publication Critical patent/GB9202915D0/en
Priority to HU9402343A priority patent/HUT72309A/en
Priority to EP93903266A priority patent/EP0625978A1/en
Priority to CA002117434A priority patent/CA2117434A1/en
Priority to CZ941949A priority patent/CZ194994A3/en
Priority to PCT/GB1993/000285 priority patent/WO1993016073A1/en
Priority to AU34603/93A priority patent/AU3460393A/en
Priority to IL104690A priority patent/IL104690A0/en
Priority to JP5513907A priority patent/JPH07503723A/en
Priority to RU94038064/04A priority patent/RU94038064A/en
Priority to ZA93958A priority patent/ZA93958B/en
Priority to SK964-94A priority patent/SK96494A3/en
Priority to MX9300786A priority patent/MX9300786A/en
Priority to FI943718A priority patent/FI943718A/en
Priority to NO942977A priority patent/NO942977L/en
Priority to KR1019940702790A priority patent/KR950700290A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
GB929202915A 1992-02-12 1992-02-12 Chemical compounds Pending GB9202915D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB929202915A GB9202915D0 (en) 1992-02-12 1992-02-12 Chemical compounds
SK964-94A SK96494A3 (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, and their use as antipsychotic
AU34603/93A AU3460393A (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, and their use as antipsychotics
JP5513907A JPH07503723A (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives and their use as antipsychotics
CA002117434A CA2117434A1 (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, and their use as antipsychotics
CZ941949A CZ194994A3 (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, process of their preparation and pharmaceutical compositions containing thereof
PCT/GB1993/000285 WO1993016073A1 (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, and their use as antipsychotics
HU9402343A HUT72309A (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, having antipsychotic activity pharmaceutical compositions containing them and process for their preparation
IL104690A IL104690A0 (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives,their preparation and pharmaceutical compositions containing them
EP93903266A EP0625978A1 (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, and their use as antipsychotics
RU94038064/04A RU94038064A (en) 1992-02-12 1993-02-11 Derivatives of piperazine and piperidine, their use as antipsychotic agents, method of their synthesis, pharmaceutical composition
ZA93958A ZA93958B (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives and their use in therapy
MX9300786A MX9300786A (en) 1992-02-12 1993-02-12 HYPOLIPIDAEMIC COMPOUNDS.
FI943718A FI943718A (en) 1992-02-12 1994-08-11 Piperazine and piperadine derivatives and their use as antipsychotics
NO942977A NO942977L (en) 1992-02-12 1994-08-11 Piperazine and piperidine derivatives and their use as antipsychotic agents
KR1019940702790A KR950700290A (en) 1992-02-12 1994-08-12 Piperazine and pyridine derivatives, and their use as antipsychotics (PIPERAZINE AND PIPERIDINE DERIVATIVES, AND THEIR USE AS ANTIPSYCHOTICS)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202915A GB9202915D0 (en) 1992-02-12 1992-02-12 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9202915D0 true GB9202915D0 (en) 1992-03-25

Family

ID=10710223

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929202915A Pending GB9202915D0 (en) 1992-02-12 1992-02-12 Chemical compounds

Country Status (16)

Country Link
EP (1) EP0625978A1 (en)
JP (1) JPH07503723A (en)
KR (1) KR950700290A (en)
AU (1) AU3460393A (en)
CA (1) CA2117434A1 (en)
CZ (1) CZ194994A3 (en)
FI (1) FI943718A (en)
GB (1) GB9202915D0 (en)
HU (1) HUT72309A (en)
IL (1) IL104690A0 (en)
MX (1) MX9300786A (en)
NO (1) NO942977L (en)
RU (1) RU94038064A (en)
SK (1) SK96494A3 (en)
WO (1) WO1993016073A1 (en)
ZA (1) ZA93958B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
RU2118322C1 (en) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-dihydro-1,4-benzodioxine-5-yl-pyrerazine derivatives and salts thereof
US5874429A (en) * 1993-12-24 1999-02-23 Suntory Limited Benzothiazine derivative
CA2156849A1 (en) * 1993-12-24 1995-07-06 Akira Mizuno Benzothiazine derivative
US6001827A (en) 1993-12-24 1999-12-14 Suntory Limited Benzothiazine derivative
JPH0912562A (en) * 1995-06-22 1997-01-14 Suntory Ltd Substituted benzothiazine derivative
WO1996014297A1 (en) * 1994-11-04 1996-05-17 Sumitomo Pharmaceuticals Company, Limited Novel lactam derivatives
EP0732332B1 (en) * 1995-03-17 2001-12-19 Aventis Pharmaceuticals Inc. Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
US6087364A (en) * 1998-01-29 2000-07-11 Warner-Lambert Company Dopamine D4 receptor antagonists
DE19814084B4 (en) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's syndrome and process for its preparation
WO2000059489A2 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
US7030142B1 (en) 1999-04-06 2006-04-18 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites
AR028685A1 (en) 2000-06-14 2003-05-21 Lundbeck & Co As H INDOL DERIVATIVES
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
DE10234673B4 (en) 2002-07-30 2007-08-16 Schwarz Pharma Ag Hot-melt TTS for the administration of rotigotine and process for its preparation, and use of rotigotine in the manufacture of a hot-melt TTS
US8246980B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
WO2004017973A1 (en) 2002-08-22 2004-03-04 Sumitomo Pharmaceuticals Company, Limited Remedy for integration dysfunction syndrome
DE10261696A1 (en) 2002-12-30 2004-07-15 Schwarz Pharma Ag Device for the transdermal administration of rotigotine base
AU2004249621B2 (en) 2003-06-23 2009-08-06 Dainippon Sumitomo Pharma Co., Ltd. Therapeutic agent for senile dementia
DE10334188B4 (en) 2003-07-26 2007-07-05 Schwarz Pharma Ag Use of rotigotine to treat depression
US20070160537A1 (en) 2004-02-20 2007-07-12 Takeo Ishiyama In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia
EA200900937A1 (en) * 2007-01-03 2009-12-30 Кортекс Фармасеутикалс, Инк. COMPOUNDS OF 3-SUBSTITUTED- [1,2,3] BENZOTRIAZINONE FOR STRENGTHENING GLUTAMATERGIC SYNAPTIC RESPONSES
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
EP2736905A4 (en) 2011-07-28 2015-07-29 Mapi Pharma Ltd Intermediate compounds and process for the preparation of lurasidone and salts thereof
ES2632988T3 (en) * 2013-07-31 2017-09-18 Merck Patent Gmbh Oxoquinazolinyl Butanamide Derivatives
CN105669665A (en) * 2016-03-15 2016-06-15 烟台贝森医药科技有限公司 Preparation method of perospirone
US11246905B2 (en) 2016-08-15 2022-02-15 President And Fellows Of Harvard College Treating infections using IdsD from Proteus mirabilis
CN115124464B (en) * 2022-07-04 2023-06-06 新乡学院 Quinoline diketone sulfonyl piperazine hybrid, and preparation method and application thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258843B1 (en) * 1974-01-30 1977-09-09 Roussel Uclaf
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
JPH0625181B2 (en) * 1985-03-27 1994-04-06 住友製薬株式会社 New imide derivative
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
JP2800953B2 (en) * 1990-07-06 1998-09-21 住友製薬株式会社 New imide derivatives

Also Published As

Publication number Publication date
ZA93958B (en) 1994-08-11
KR950700290A (en) 1995-01-16
JPH07503723A (en) 1995-04-20
EP0625978A1 (en) 1994-11-30
CZ194994A3 (en) 1995-09-13
RU94038064A (en) 1997-05-27
NO942977D0 (en) 1994-08-11
IL104690A0 (en) 1993-06-10
AU3460393A (en) 1993-09-03
FI943718A0 (en) 1994-08-11
SK96494A3 (en) 1995-07-11
FI943718A (en) 1994-08-11
NO942977L (en) 1994-10-10
MX9300786A (en) 1994-03-31
HUT72309A (en) 1996-04-29
HU9402343D0 (en) 1994-10-28
WO1993016073A1 (en) 1993-08-19
CA2117434A1 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
GB9201179D0 (en) Chemical compounds
GB9201180D0 (en) Chemical compounds
GB9201038D0 (en) Chemical compounds
GB9202915D0 (en) Chemical compounds
GB9208740D0 (en) Chemical compounds
AP9300585A0 (en) Chemical compounds
GB9207964D0 (en) Chemical compounds
GB9209076D0 (en) Chemical compounds
GB9206989D0 (en) Chemical compounds
GB9205136D0 (en) Chemical compounds
GB9205140D0 (en) Chemical compounds
GB9200389D0 (en) Chemical compounds
GB9201184D0 (en) Chemical compounds
GB9206668D0 (en) Chemical compounds
GB9209075D0 (en) Chemical compounds
GB9215606D0 (en) Chemical compounds
GB9205133D0 (en) Chemical compounds
GB9204757D0 (en) Chemical compounds
GB9201802D0 (en) Chemical compounds
GB9205879D0 (en) Chemical compounds
GB9201029D0 (en) Chemical compounds
GB9208742D0 (en) Chemical compounds
GB9204756D0 (en) Chemical compounds
GB9209031D0 (en) Chemical compounds
GB9201821D0 (en) Chemical compounds